Optimizing the Strategy for Preoperative Chemotherapy in Locally Advanced Gastric/Gastroesophageal Cancer
Status:
Completed
Trial end date:
2019-06-01
Target enrollment:
Participant gender:
Summary
This is a randomized,phase II,open-label study, The purpose of this study is to determine the
optimal treatment for patients with locally advanced Gastric/Gastroesophageal Cancer
according to their Her-2 expression status.
The primary endpoint of this study: pathology response rate the second endpoints of this
study:pathology complete response rate R0 resection rate Progression-free survival ( PFS)
Disease -free survival (DFS) Overall survival(OS) Objective response rate(ORR) Adverse
event(AE)